DLin-MC3-DMA [1224606-06-7]
Cat# orb507413-100mg
Size : 100mg
Brand : Biorbyt
Contact local distributor :
Phone : +1 850 650 7790
DLin-MC3-DMA
Description
Research Area
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| CAS Number | 1224606-06-7 |
|---|---|
| MW | 641.61 |
| Purity | >98% |
| Formula | C43H79NO2 |
| SMILES | CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC |
Storage & Handling
−| Storage | Pure form: -20°C/3 years,4°C/2 years; In solvent: -20°C/1 month |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Hazard Information | Non-Toxic |
| Disclaimer | For research use only |
Alternative Names
−
Dlin-MeOH [orb1983102]
99.95% (May vary between batches)
1169768-28-8
528.94
C37H68O
50 mg, 1 ml x 10 mM (in DMSO), 5 mg, 10 mg, 25 mg, 100 mg, 500 mg, 2 mg
Compound Identifiers
Key Properties
−Protocol Information
Ye Zeng 1, Mariona Estapé Senti 2, M Clara I Labonia 3, Panagiota Papadopoulou 1, Maike A D Brans 3, Inge Dokter 3 4, Marcel H Fens 5, Alain van Mil 3 4, Joost P G Sluijter 3 4, Raymond M Schiffelers 2, Pieter Vader 2 3, Alexander Kros 1 Fusogenic Coiled-Coil Peptides Enhance Lipid Nanoparticle-Mediated mRNA Delivery upon Intramyocardial Administration ACS Nano, 17(23), 23466–23477 (2023)
Applications
Reactivity
Gangyin Zhao 1 2, Ye Zeng 3, Wanli Cheng 4, Sofia Karkampouna 4 5, Panagiota Papadopoulou 3, Bochuan Hu 3, Shuya Zang 3, Emma Wezenberg 3, Gabriel Forn-Cuní 1, Bruno Lopes-Bastos 1, Marianna Kruithof-de Julio 5, Alexander Kros 3, B Ewa Snaar-Jagalska 1 Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics ACS Nano, (2025)
Hend Mohamed Abdel-Bar et al. Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo ACS Nano, 19(50), 42658-42674 (2025)
Applications
Reactivity